673 related articles for article (PubMed ID: 29127110)
41. Progressing neurobiological strategies against proteostasis failure: Challenges in neurodegeneration.
Amanullah A; Upadhyay A; Joshi V; Mishra R; Jana NR; Mishra A
Prog Neurobiol; 2017 Dec; 159():1-38. PubMed ID: 28870769
[TBL] [Abstract][Full Text] [Related]
42. A review on protein misfolding, aggregation and strategies to prevent related ailments.
Shamsi TN; Athar T; Parveen R; Fatima S
Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
[TBL] [Abstract][Full Text] [Related]
43. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.
Brehme M; Voisine C; Rolland T; Wachi S; Soper JH; Zhu Y; Orton K; Villella A; Garza D; Vidal M; Ge H; Morimoto RI
Cell Rep; 2014 Nov; 9(3):1135-50. PubMed ID: 25437566
[TBL] [Abstract][Full Text] [Related]
44. Aging and Proteins: What Does Proteostasis Have to Do with Age?
Magalhaes S; Goodfellow BJ; Nunes A
Curr Mol Med; 2018; 18(3):178-189. PubMed ID: 30198430
[TBL] [Abstract][Full Text] [Related]
45. Functional Modules of the Proteostasis Network.
Jayaraj GG; Hipp MS; Hartl FU
Cold Spring Harb Perspect Biol; 2020 Jan; 12(1):. PubMed ID: 30833457
[TBL] [Abstract][Full Text] [Related]
46. The first Autumn School on Proteostasis: from molecular mechanisms to organismal consequences.
Boczek E; Gaglia G; Olshina M; Sarraf S
Cell Stress Chaperones; 2019 May; 24(3):481-492. PubMed ID: 31073902
[TBL] [Abstract][Full Text] [Related]
47. Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases: progress and prognosis.
Lindquist SL; Kelly JW
Cold Spring Harb Perspect Biol; 2011 Dec; 3(12):. PubMed ID: 21900404
[TBL] [Abstract][Full Text] [Related]
48. Does proteostasis get lost in translation? Implications for protein aggregation across the lifespan.
Francisco S; Ferreira M; Moura G; Soares AR; Santos MAS
Ageing Res Rev; 2020 Sep; 62():101119. PubMed ID: 32603841
[TBL] [Abstract][Full Text] [Related]
49. Disease-modifying therapy for proteinopathies: Can the exception become the rule?
Bitan G
Prog Mol Biol Transl Sci; 2019; 168():277-287. PubMed ID: 31699321
[TBL] [Abstract][Full Text] [Related]
50. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.
Saxena S; Caroni P
Neuron; 2011 Jul; 71(1):35-48. PubMed ID: 21745636
[TBL] [Abstract][Full Text] [Related]
51. The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.
Elmatboly AM; Sherif AM; Deeb DA; Benmelouka A; Bin-Jumah MN; Aleya L; Abdel-Daim MM
Environ Sci Pollut Res Int; 2020 Apr; 27(11):11461-11483. PubMed ID: 32072427
[TBL] [Abstract][Full Text] [Related]
52. Involvement of molecular chaperone in protein-misfolding brain diseases.
Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
[TBL] [Abstract][Full Text] [Related]
53. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
54. Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress.
Höhn A; Tramutola A; Cascella R
Oxid Med Cell Longev; 2020; 2020():5497046. PubMed ID: 32308803
[TBL] [Abstract][Full Text] [Related]
55. Aging of the brain, dementias, role of infectious proteins: facts and theories.
Morinet F
Interdiscip Top Gerontol; 2014; 39():177-86. PubMed ID: 24862020
[TBL] [Abstract][Full Text] [Related]
56. Chaperone networks: tipping the balance in protein folding diseases.
Voisine C; Pedersen JS; Morimoto RI
Neurobiol Dis; 2010 Oct; 40(1):12-20. PubMed ID: 20472062
[TBL] [Abstract][Full Text] [Related]
57. Molecular chaperones: from proteostasis to pathogenesis.
Ravindran MS
FEBS J; 2018 Sep; 285(18):3353-3361. PubMed ID: 29890022
[TBL] [Abstract][Full Text] [Related]
58. Molecular chaperones biochemistry and role in neurodegenerative diseases.
Chaari A
Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
[TBL] [Abstract][Full Text] [Related]
59. Molecular chaperones in protein folding and proteostasis.
Hartl FU; Bracher A; Hayer-Hartl M
Nature; 2011 Jul; 475(7356):324-32. PubMed ID: 21776078
[TBL] [Abstract][Full Text] [Related]
60. Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated.
Olzscha H
Biol Chem; 2019 Jun; 400(7):895-915. PubMed ID: 30998500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
